{"id":"W4292330677","doi":"10.1016/j.ajpc.2022.100372","title":"Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease","year":2022,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Resverlogix (Canada)","funders":"Kowa Company; National Institute on Handicapped Research; Roche; Silence Therapeutics; Amgen; Pfizer; AbbVie; Merck; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Mace; Type 2 Diabetes Mellitus; Acute coronary syndrome; Myocardial infarction; Cirrhosis; Placebo; Cardiology; Nonalcoholic fatty liver disease; Type 2 diabetes; Gastroenterology; Diabetes mellitus; Disease; Percutaneous coronary intervention; Fatty liver; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006751032,0.0001361231,0.0004316607,0.0001061919,0.00005625472,0.000002489433,0.0001887917,0.00002705385,0.000002953535],"category_scores_gemma":[0.00004065481,0.00008329289,0.0001239531,0.0003509242,0.0002134716,0.00001389394,0.0001219151,0.0002229627,1.644252e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004209201,"about_ca_system_score_gemma":0.0001166829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004524218,"about_ca_topic_score_gemma":0.000005486007,"domain_scores_codex":[0.9979419,0.001095771,0.0003019055,0.0002142661,0.0002759794,0.0001702315],"domain_scores_gemma":[0.9989982,0.00001407647,0.0004486677,0.0002617837,0.0002157478,0.00006155251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01314969,0.0007233993,0.9290708,0.00005608372,0.005185369,0.0001268282,0.0009304757,0.01114232,0.02039188,0.000005352347,0.0002425944,0.01897526],"study_design_scores_gemma":[0.002012807,0.006086001,0.9864114,0.0000560797,0.000325927,0.00005006989,0.0004815758,0.000006492117,0.004270358,0.00001664325,0.0001543958,0.0001282802],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980456,0.0006284128,0.0002439664,0.0001072229,0.0000616109,0.000829178,0.000080424,8.394035e-7,0.000002697678],"genre_scores_gemma":[0.9992752,0.0002203558,0.0002835617,0.00004514861,0.00003047347,0.00008061234,0.0000456933,0.00001345374,0.000005501503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05734063,"threshold_uncertainty_score":0.3396585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002899546858357316,"score_gpt":0.1897503837880307,"score_spread":0.1868508369296734,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}